MAP1LC3A and breast carcinoma: In line with the results of these studies, lower LC3 or beclin-1 protein expression has also been found in cancer cells than in adjacent normal tissues in various human malignancies, including ovarian cancers [30], breast cancers [31], and esophageal cancers [32].